Atlas Trials

Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer

Clinical trial NCT00547612 · COMPLETED

Trial details

NCT number
NCT00547612
Sponsor
National Institutes of Health Clinical Center (CC)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2007-09-01
Primary completion
2008-12-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.